Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.49 |
| ▸ | PRKCA | P17252 | 6/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8922718 | 0.94 | NAAA (0.54) | NAAAPRKCAALOX5DGKATSHR | |
| SCHEMBL30947774 | 0.85 | ALOX5 (0.38) | NAAAPRKCAALOX5CTSK | |
| SCHEMBL22642652 | 0.84 | PRKCA (0.47) | NAAAPRKCAALOX5DGKA | |
| SCHEMBL18970778 | 0.82 | PRKCA (0.46) | NAAAPRKCAALOX5DGKA | |
| SCHEMBL11284017 | 0.78 | NAAA (0.58) | NAAAPRKCAALOX5DGKALMNA | |
| SCHEMBL22920283 | 0.78 | PRKCA (0.42) | NAAAPRKCAALOX5DGKATSHR | |
| SCHEMBL4941578 | 0.76 | NAAA (0.68) | NAAAPRKCADGKALMNA | |
| SCHEMBL12820058 | 0.73 | PRKCA (0.43) | NAAAPRKCA | |
| SCHEMBL2505317 | 0.73 | ALOX5 (0.62) | NAAAALOX5DGKATSHRLMNA | |
| SCHEMBL16174233 | 0.73 | ALOX5 (0.62) | NAAAALOX5DGKATSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120129674-A | Cationic lipids and methods of making the same | 三养控股公司 | 2025-06-10 | — | — | CN | disclosed |
| WO-2024106715-A1 | CATIONIC LIPIDS AND METHOD FOR PREPARING SAME | 주식회사 삼양홀딩스 | 2024-05-23 | — | — | WO | disclosed |